NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022
NuCana plc - American Depositary Shares (NCNA)
Last nucana plc - american depositary shares earnings: 3/10 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/ncna/historical
Company Research
Source: GlobeNewswire
EDINBURGH, United Kingdom, Sept. 06, 2022 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced two presentations at the European Society for Medical Oncology (ESMO) Congress 2022 being held September 9-13, 2022 at the Paris Expo Porte de Versailles in Paris, France. The details of NuCana’s presentations at ESMO are as follows: Title: NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)Abstract Number: 1752Presentation: 345PPresentation Date & Time: Sunday, September 11, 2022 at 9:00 a.m. CESTLocation: Hall 4 and the virtual Congress platformPresenting Author: Andrew L. Coveler Title: NUC-7738 in patients with advanced solid tumours: Phase I results from the NuTide:701 phase I/2 studyAbstract Number: 4992Presentation: 455MOPresentation Date & Time: Monday, September 12, 2022 at 4:30 p.m. CESTLocation: Toulouse AuditoriumPresenting Author: Stefan N. Symeonides Ab
Show less
Read more
Impact Snapshot
Event Time:
NCNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NCNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NCNA alerts
High impacting NuCana plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
NCNA
News
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study [Yahoo! Finance]Yahoo! Finance
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical StudyGlobeNewswire
- NuCana plc (NASDAQ: NCNA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $4.00 price target on the stock.MarketBeat
- NuCana Announces Plan to Implement ADS Ratio Change [Yahoo! Finance]Yahoo! Finance
- NuCana Announces Plan to Implement ADS Ratio ChangeGlobeNewswire
NCNA
Sec Filings
- 4/9/24 - Form 6-K
- 3/27/24 - Form F-6
- 3/27/24 - Form 424B5
- NCNA's page on the SEC website